By implementing actions to improve medical services, 87% of public hospitals at or above the second level have provided appointment diagnosis and treatment services, and 83% of public hospitals at the third level have provided day surgery services; In 2024, the number of two-way medical referrals nationwide will reach 36 million, an increase of 46% compared to 2020, saving people the cost and time of medical treatment.
During the 14th Five Year Plan period, China's medical, medical insurance, and pharmaceutical industries will develop in a coordinated manner, and the number of residents covered by basic medical insurance will remain above 1.3 billion, stabilizing at around 95%. Over the past five years, 560 million people across provinces in China have benefited from direct settlement of medical treatment in other places, resulting in a cumulative reduction of 590 billion yuan in advance payments for insured individuals; By 2025, the total number of drugs in the national medical insurance catalog will reach 3159, covering chronic diseases, childhood diseases, and other fields. Many drugs that were previously unaffordable for the general public have entered the medical insurance catalog.
At the end of the 14th Five Year Plan, China's healthcare industry has delivered a warm and substantial answer to the people's livelihood, allowing the sunshine of high-quality medical services to shine into every corner and benefit everyone.

